ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene.

Mamata Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.